The effects of bioactive compounds on Alzheimer’s disease and mild cognitive impairment
Journal Title: Functional Foods in Health and Disease - Year 2016, Vol 6, Issue 6
Abstract
Prevalence rates of Alzheimer’s disease are increasing in countries around world, and identifying effective treatments to manage cognitive impairment and neurodegeneration has become a global health priority. Decades of scientific research have developed a more comprehensive understanding of the Alzheimer’s Disease and Mild Cognitive Impairment (MCI), a transitional stage of accelerated cognitive decline. This understanding has allowed researchers to envision novel Alzheimer’s Disease therapies, including the use of bioactive compounds found in plants and animals. Within the past 15 years, a significant amount of clinical research has been published documenting the effects specific bioactive compounds have on patients with Alzheimer’s Disease and MCI. This article reviews the results of this research, and discusses whether sufficient evidence exists to support the use of specific bioactive compounds by individuals diagnosed with Alzheimer’s Disease and MCI. Information on relevant epidemiological studies, outcome measures, and disease pathologies is provided to enrich this discussion.
Authors and Affiliations
Brian McAnany, Danik M. Martirosyan
Keywords
Related Articles
- EP ID EP457738
- DOI 10.31989/ffhd.v6i6.257
- Views 110
- Downloads 0
Drought stress affects bioactive compounds in potatoes (Solanum tuberosum L.) relevant to non-communicable diseases
Background: Potatoes react very sensitive to drought during growth, and appropriate plant stress responses may affect metabolites associated with the health quality of tubers. Objective: The aim of this study is to dete...
Recent researches on prebiotics for gut health in Thailand
Background: In the food industries, several oligosaccharides have received increasing attention as key components for functional foods and nutraceutical products. Prebiotics are non-digestible oligosaccharides which have...
Seaweed Fucoxanthin Supplementation Improves Obesity Parameters in Mild Obese Japanese Subjects
Background: Fucoxanthin is a seaweed xanthophyll that has demonstrated an anti-obesity effect in rodents. However, clinical investigations of its influence on mildly obese subjects has not been performed. We conducted a...
Daily consumption of monoglucosyl-rutin prevents high-fat diet-induced obesity by suppressing gastric inhibitory polypeptide secretion in mice
Background: Alpha monoglucosyl-rutin (4G-α-D-glucopyranosyl rutin, αMR) has been shown to stimulate antioxidant defenses and anti-glycation. We evaluated the effects of αMR on body weight gain in mice. Methods: Male C57...
Experimental Comparative Study of potential anxiolytic effect of Vitamin C and Buspirone in rats
Background: Anxiety disorders are the most common of all mental health problems. They are more prevalent among women than among men, and they affect children as well as adults. The aim of the current study is to evaluate...